Carvlin, M J <br/><br/>
Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.  [electronic resource] 

 -  Investigative radiology  Aug 1992 
 - S16-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0020-9996 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Brain--pathology<br/>Brain Neoplasms--diagnosis<br/>Contrast Media--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation<br/>Drug Tolerance<br/>Gadolinium--administration & dosage<br/>Heterocyclic Compounds--administration & dosage<br/>Humans<br/>Magnetic Resonance Imaging<br/>Middle Aged<br/>Organometallic Compounds--administration & dosage<br/>Time Factors